title: FDA approves two new technetium-labeled cardiac agents and a pharmacologic alternative to exercise in stress-thallium studies.
authors.forename: P R
authors.initials: PR
authors.lastname: Ghosh
mesh_terms: D003327:Coronary Disease / Q000175:diagnosis* / Q000000981:diagnostic imaging; D004176:Dipyridamole; D006801:Humans; D015609:Organotechnetium Compounds; D010091:Oximes; D011877:Radionuclide Imaging; D017256:Technetium Tc 99m Sestamibi
chemical_list: D015609:Organotechnetium Compounds; D010091:Oximes; D004176:Dipyridamole; D017256:Technetium Tc 99m Sestamibi; C060156:technetium Tc 99m teboroxime